LCTX – lineage cell therapeutics, inc. (US:NASDAQ)

News

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience
Lineage Cell Therapeutics Issues Letter to Stockholders
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy [Seeking Alpha]
Dimension Bio Announces Inaugural Clinical and Scientific Advisory Boards
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com